Top

CardioVascular and Interventional Radiology

Published in:

01-04-2014 | Technical Note

Ultrasound-Guided Transhepatic Radiofrequency Ablation of Renal Tumors: A Safe and Effective Approach

Authors: Ryan M. Hegg, Grant D. Schmit, A. Nicholas Kurup, Adam J. Weisbrod, Stephen A. Boorjian, Thomas D. Atwell

Published in: CardioVascular and Interventional Radiology | Issue 2/2014

Abstract

Purpose

This study was designed to determine the feasibility and safety of ultrasound-guided transhepatic radiofrequency ablation (RFA) of masses in the right kidney.

Methods

Between June 2001 and December 2011, 18 patients who underwent transhepatic renal RFA procedures to treat 19 tumors were retrospectively identified. Complications (Clavien–Dindo classification system) and local tumor control were evaluated for all patients.

Results

Median maximal diameter of the treated renal tumors was 1.9 (range 1.1–4.3) cm. No major complication developed during any of the procedures. No hepatic tumor seeding was identified during imaging follow-up. There was a single technical failure (5.3 %). Median cross-sectional imaging follow-up was 28 (range 3–121) months. Primary technique failure (local recurrence) occurred in 1 of the 16 tumors with follow-up imaging (5.3 %).

Conclusions

Percutaneous ultrasound-guided transhepatic RFA of renal neoplasms is technically feasible, effective, and associated with a low rate of complications. The transhepatic approach may allow safe ablation of renal tumors that would otherwise be difficult to treat.

Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279PubMedCrossRef

McGahan JP, Ro KM, Evans CP, Ellison LM (2006) Efficacy of transhepatic radiofrequency ablation of renal cell carcinoma. AJR Am J Roentgenol 186:S311–S315PubMedCrossRef

Iguchi T, Hiraki T, Gobara H, Mukai T, Hase S, Fujiwara H, Tajiri N, Sakurai J, Mimura H, Saika T, Kumon H, Kanazawa S (2007) Transhepatic approach for percutaneous computed-tomography-guided radiofrequency ablation of renal cell carcinoma. Cardiovasc Intervent Radiol 30(4):765–769PubMedCrossRef

Bodily KD, Atwell TD, Mandrekar JN, Farrell MA, Callstrom MR, Schmit GD, Charboneau JW (2010) Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. AJR Am J Roentgenol 194(3):779–783PubMedCrossRef

Cantwell CP, Wah TM, Gervais DA, Eisner BH, Arellano R, Uppot RN, Samir AE, Irving HC, McGovern F, Mueller PR (2008) Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5 % in water. J Vasc Interv Radiol 19(7):1034–1040PubMedCrossRef

Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, Thompson RH, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE (2012) Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol 23(1):48–54PubMedCrossRef

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCentralPubMedCrossRef

Price RB, Bernardino ME, Berkman WA, Sones PJ, Torres WE (1983) Biopsy of the right adrenal gland by the transhepatic approach. Radiology 148(2):566PubMed

Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swenson SJ (1994) Percutaneous adrenal biopsy: review of a 10 year experience. Radiology 193(2):341–344PubMed

10.

Mody MK, Kazerooni EA, Korobkin M (1995) Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 19(3):434–439PubMedCrossRef

11.

Brown DB, Gonsalves CF (2008) Percutaneous biopsy before interventional oncologic therapy: current status. J Vasc Interv Radiol 19(7):973–979PubMedCrossRef

12.

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais D (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63(3):486–492PubMedCrossRef

13.

Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189(2):429–436PubMedCrossRef

Title: Ultrasound-Guided Transhepatic Radiofrequency Ablation of Renal Tumors: A Safe and Effective Approach
Authors: Ryan M. Hegg
Grant D. Schmit
A. Nicholas Kurup
Adam J. Weisbrod
Stephen A. Boorjian
Thomas D. Atwell
Publication date: 01-04-2014
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 2/2014
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-013-0716-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ultrasound-Guided Transhepatic Radiofrequency Ablation of Renal Tumors: A Safe and Effective Approach

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2014

Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours

Re-TEVAR for Complications After Blunt Aortic Traumatic Injury Stenting

Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional Radiology

Deep Pelvic Postprostatectomy Pseudoaneurysm Treated by Transrectal Ultrasound-Guided Thrombin Injection

Percutaneous Minimally Invasive Treatment of Malignant Biliary Strictures: Current Status

Transrenal Ureteral Occlusion Using the Amplatzer Vascular Plug II: A New Interventional Treatment Option for Lower Urinary Tract Fistulas